These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 17392392)

  • 1. Selective toxicity of aristolochic acids I and II.
    Shibutani S; Dong H; Suzuki N; Ueda S; Miller F; Grollman AP
    Drug Metab Dispos; 2007 Jul; 35(7):1217-22. PubMed ID: 17392392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detoxification of aristolochic acid I by O-demethylation: less nephrotoxicity and genotoxicity of aristolochic acid Ia in rodents.
    Shibutani S; Bonala RR; Rosenquist T; Rieger R; Suzuki N; Johnson F; Miller F; Grollman AP
    Int J Cancer; 2010 Sep; 127(5):1021-7. PubMed ID: 20039324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative determination of aristolochic acid-derived DNA adducts in rats using 32P-postlabeling/polyacrylamide gel electrophoresis analysis.
    Dong H; Suzuki N; Torres MC; Bonala RR; Johnson F; Grollman AP; Shibutani S
    Drug Metab Dispos; 2006 Jul; 34(7):1122-7. PubMed ID: 16611860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review.
    Arlt VM; Stiborova M; Schmeiser HH
    Mutagenesis; 2002 Jul; 17(4):265-77. PubMed ID: 12110620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of biotransformation enzymes in the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions and difficult answers.
    Stiborova M; Frei E; Arlt VM; Schmeiser HH
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):5-11. PubMed ID: 19365519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Hájek M; Frei E; Schmeiser HH
    Gen Physiol Biophys; 2001 Dec; 20(4):375-92. PubMed ID: 11989648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Frei E; Breuer A; Bieler CA; Schmeiser HH
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):421-7. PubMed ID: 10445409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-Exposure to Aristolochic Acids I and II Increases DNA Adduct Formation Responsible for Aristolochic Acid I-Mediated Carcinogenicity in Rats.
    Bárta F; Dedíková A; Bebová M; Dušková Š; Mráz J; Schmeiser HH; Arlt VM; Hodek P; Stiborová M
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Aristolochic acid I derived DNA adduct levels in human renal toxicity models.
    Bastek H; Zubel T; Stemmer K; Mangerich A; Beneke S; Dietrich DR
    Toxicology; 2019 May; 420():29-38. PubMed ID: 30940547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dexfenfluramine on aristolochic acid nephrotoxicity in a rat model for Chinese-herb nephropathy.
    Debelle F; Nortier J; Arlt VM; De Prez E; Vienne A; Salmon I; Phillips DH; Deschodt-Lanckman M; Vanherweghem JL
    Arch Toxicol; 2003 Apr; 77(4):218-26. PubMed ID: 12698237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive measurement of aristolochic acid-DNA adducts in urine samples from aristolochic acid-treated rats by liquid chromatography coupled tandem mass spectrometry: evidence for DNA repair by nucleotide-excision repair mechanisms.
    Leung EM; Chan W
    Mutat Res; 2014; 766-767():1-6. PubMed ID: 25847264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for reductive activation of carcinogenic aristolochic acids by prostaglandin H synthase -- (32)P-postlabeling analysis of DNA adduct formation.
    Stiborová M; Frei E; Breuer A; Wiessler M; Schmeiser HH
    Mutat Res; 2001 Jun; 493(1-2):149-60. PubMed ID: 11516724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the nephrotoxicity and safety of low-dose aristolochic acid, extending to the use of Xixin (Asurum), by determination of methylglyoxal and d-lactate.
    Lin CE; Lin PY; Yang WC; Huang YS; Lin TY; Chen CM; Chen HS; Lee JA; Chen SM
    J Ethnopharmacol; 2021 May; 272():113945. PubMed ID: 33617966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA Adducts Formed by Aristolochic Acid Are Unique Biomarkers of Exposure and Explain the Initiation Phase of Upper Urothelial Cancer.
    Stiborová M; Arlt VM; Schmeiser HH
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy.
    Bieler CA; Stiborova M; Wiessler M; Cosyns JP; van Ypersele de Strihou C; Schmeiser HH
    Carcinogenesis; 1997 May; 18(5):1063-7. PubMed ID: 9163697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity and genotoxicity of the carcinogen aristolochic acid I (AA-I) in human bladder RT4 cells.
    Bellamri M; Brandt K; Brown CV; Wu MT; Turesky RJ
    Arch Toxicol; 2021 Jun; 95(6):2189-2199. PubMed ID: 33938965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver.
    Mei N; Arlt VM; Phillips DH; Heflich RH; Chen T
    Mutat Res; 2006 Dec; 602(1-2):83-91. PubMed ID: 17010389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotransformation enzymes in development of renal injury and urothelial cancer caused by aristolochic acid.
    Stiborová M; Frei E; Schmeiser HH
    Kidney Int; 2008 Jun; 73(11):1209-11. PubMed ID: 18480852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Frei E; Sopko B; Wiessler M; Schmeiser HH
    Carcinogenesis; 2002 Apr; 23(4):617-25. PubMed ID: 11960915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical and molecular basis of the carcinogenicity of Aristolochia plants.
    Schmeiser HH; Stiborovà M; Arlt VM
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):141-8. PubMed ID: 19152223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.